Novo Nordisk is considering laying-off up to 3,000 staff and dropping its long-term financial targets due to challenging market conditions in the United States, Danish daily Borsen reported Thursday citing unnamed sources.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,